» Articles » PMID: 23861985

A Reporter Screen in a Human Haploid Cell Line Identifies CYLD As a Constitutive Inhibitor of NF-κB

Overview
Journal PLoS One
Date 2013 Jul 18
PMID 23861985
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

The development of forward genetic screens in human haploid cells has the potential to transform our understanding of the genetic basis of cellular processes unique to man. So far, this approach has been limited mostly to the identification of genes that mediate cell death in response to a lethal agent, likely due to the ease with which this phenotype can be observed. Here, we perform the first reporter screen in the near-haploid KBM7 cell line to identify constitutive inhibitors of NF-κB. CYLD was the only currently known negative regulator of NF-κB to be identified, thus uniquely distinguishing this gene. Also identified were three genes with no previous known connection to NF-κB. Our results demonstrate that reporter screens in haploid human cells can be applied to investigate the many complex signaling pathways that converge upon transcription factors.

Citing Articles

Genomic Characterization of Prostatic Basal Cell Carcinoma.

Low J, Ko M, Hanratty B, Patel R, Bhamidipati A, Heaphy C Am J Pathol. 2022; 193(1):4-10.

PMID: 36309102 PMC: 9768679. DOI: 10.1016/j.ajpath.2022.09.010.


A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency.

Roling M, Sisakht M, Ne E, Moulos P, Crespo R, Stoszko M mBio. 2021; 12(6):e0298021.

PMID: 34872356 PMC: 8649776. DOI: 10.1128/mBio.02980-21.


Tumor Necrosis Factor-alpha utilizes MAPK/NFκB pathways to induce cholesterol-25 hydroxylase for amplifying pro-inflammatory response via 25-hydroxycholesterol-integrin-FAK pathway.

Pokharel S, Chiok K, Shil N, Mohanty I, Bose S PLoS One. 2021; 16(9):e0257576.

PMID: 34551004 PMC: 8457477. DOI: 10.1371/journal.pone.0257576.


A genome-wide enrichment screen identifies NUMA1-loss as a resistance mechanism against mitotic cell-death induced by BMI1 inhibition.

Gisler S, Maia A, Chandrasekaran G, Kopparam J, van Lohuizen M PLoS One. 2020; 15(4):e0227592.

PMID: 32343689 PMC: 7188281. DOI: 10.1371/journal.pone.0227592.


A genome-wide CRISPR screen identifies regulation factors of the TLR3 signalling pathway.

Zablocki-Thomas L, Menzies S, Lehner P, Manel N, Benaroch P Innate Immun. 2020; 26(6):459-472.

PMID: 32248720 PMC: 7491238. DOI: 10.1177/1753425920915507.


References
1.
Tominaga K, Kondo C, Kagata T, Hishida T, Nishizuka M, Imagawa M . The novel gene fad158, having a transmembrane domain and leucine-rich repeat, stimulates adipocyte differentiation. J Biol Chem. 2004; 279(33):34840-8. DOI: 10.1074/jbc.M312927200. View

2.
Kovalenko A, Chable-Bessia C, Cantarella G, Israel A, Wallach D, Courtois G . The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature. 2003; 424(6950):801-5. DOI: 10.1038/nature01802. View

3.
Hayashi T, Nozaki Y, Nishizuka M, Ikawa M, Osada S, Imagawa M . Factor for adipocyte differentiation 158 gene disruption prevents the body weight gain and insulin resistance induced by a high-fat diet. Biol Pharm Bull. 2011; 34(8):1257-63. DOI: 10.1248/bpb.34.1257. View

4.
Jolma A, Yan J, Whitington T, Toivonen J, Nitta K, Rastas P . DNA-binding specificities of human transcription factors. Cell. 2013; 152(1-2):327-39. DOI: 10.1016/j.cell.2012.12.009. View

5.
Sun S . CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ. 2009; 17(1):25-34. PMC: 5848464. DOI: 10.1038/cdd.2009.43. View